All In Biotech

Drug Trial Radar · NCT02373137

Descemet Endothelial Thickness Comparison Trial

Last checked: Nov 20, 2026Latest source record: Nov 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownResults posted on the registry

Status

Status unknown

Enrollment

38

Actual

Start

Jan 22, 2015

Primary completion

Apr 4, 2018

Study completion May 30, 2023

Sponsor

Lead sponsor
Oregon Health and Science UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of California, San Francisco; Stanford University
First posted
Feb 26, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.

Conditions

  • Keratoplasty
  • Grafting, Corneal
  • Transplantation, Corneal
  • Transplantation, Cornea
  • Keratoplasty, Lamellar

Interventions

  • DSAEKProcedure

  • DMEKProcedure

  • EndoserterDevice

    The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument.

  • PrednisoloneDrug

    Prednisolone is a corticosteroid used to alleviate swelling post-surgery.

  • OfloxacinDrug

    Ofloxacin is an antibiotic used to treat bacterial infections of the eye.

  • TropicamideDrug

    Tropicamide is a prescription drug used to dilate pupils during an eye exam.

  • PhenylephrineDrug

    Phenylephrine is a prescription drug used to dilate pupils during an eye exam.

  • Jones TubeDevice

    The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Best Spectacle-Corrected Visual AcuityTime frame: 6 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Byers Eye Institute, Stanford University

    Palo Alto, California

  • F. I. Proctor Foundation, University of California, San Francisco

    San Francisco, California

  • Casey Eye Institute, Oregon Health & Science University

    Portland, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.